| pubmed-article:143541 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:143541 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:143541 | lifeskim:mentions | umls-concept:C0229960 | lld:lifeskim |
| pubmed-article:143541 | lifeskim:mentions | umls-concept:C0178602 | lld:lifeskim |
| pubmed-article:143541 | lifeskim:mentions | umls-concept:C1704711 | lld:lifeskim |
| pubmed-article:143541 | lifeskim:mentions | umls-concept:C0013852 | lld:lifeskim |
| pubmed-article:143541 | lifeskim:mentions | umls-concept:C0037633 | lld:lifeskim |
| pubmed-article:143541 | lifeskim:mentions | umls-concept:C0205375 | lld:lifeskim |
| pubmed-article:143541 | lifeskim:mentions | umls-concept:C0205124 | lld:lifeskim |
| pubmed-article:143541 | lifeskim:mentions | umls-concept:C1546466 | lld:lifeskim |
| pubmed-article:143541 | pubmed:issue | 9 | lld:pubmed |
| pubmed-article:143541 | pubmed:dateCreated | 1977-11-25 | lld:pubmed |
| pubmed-article:143541 | pubmed:abstractText | In treating mycosis fungoides (MF) and Sezary syndrome patients with electron beam, the entire thickness and the area of the skin from crown to sole should be irradiated uniformly. To achieve irradiation of the entire thickness of the skin, electron beams of 3 - 4 MeV energy with 80 percent depth dose at 6 mm is sufficient. This unique property of limited penetration of electron beam does not cause any systemic toxicity during or after total body electron therapy. However, this property of limited penetration of electrons poses the problem of self-shielding in the curvaceous human body. The optic lens, which is within the range of penetrability of electron beam energy used for total body electron therapy, is to be shielded artificially.The purpose of this paper is to discuss the problems of self and artificial shielding in the superficial total body electron therapy for MF and Sezary syndrome. | lld:pubmed |
| pubmed-article:143541 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:143541 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:143541 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:143541 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:143541 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:143541 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:143541 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:143541 | pubmed:language | eng | lld:pubmed |
| pubmed-article:143541 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:143541 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:143541 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:143541 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:143541 | pubmed:issn | 0027-9684 | lld:pubmed |
| pubmed-article:143541 | pubmed:author | pubmed-author:KumarP PPP | lld:pubmed |
| pubmed-article:143541 | pubmed:author | pubmed-author:HenschkeU KUK | lld:pubmed |
| pubmed-article:143541 | pubmed:author | pubmed-author:NibhanupudyJ... | lld:pubmed |
| pubmed-article:143541 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:143541 | pubmed:volume | 69 | lld:pubmed |
| pubmed-article:143541 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:143541 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:143541 | pubmed:pagination | 645-7 | lld:pubmed |
| pubmed-article:143541 | pubmed:dateRevised | 2010-10-26 | lld:pubmed |
| pubmed-article:143541 | pubmed:meshHeading | pubmed-meshheading:143541-H... | lld:pubmed |
| pubmed-article:143541 | pubmed:meshHeading | pubmed-meshheading:143541-S... | lld:pubmed |
| pubmed-article:143541 | pubmed:meshHeading | pubmed-meshheading:143541-M... | lld:pubmed |
| pubmed-article:143541 | pubmed:meshHeading | pubmed-meshheading:143541-E... | lld:pubmed |
| pubmed-article:143541 | pubmed:meshHeading | pubmed-meshheading:143541-D... | lld:pubmed |
| pubmed-article:143541 | pubmed:meshHeading | pubmed-meshheading:143541-K... | lld:pubmed |
| pubmed-article:143541 | pubmed:meshHeading | pubmed-meshheading:143541-L... | lld:pubmed |
| pubmed-article:143541 | pubmed:meshHeading | pubmed-meshheading:143541-F... | lld:pubmed |
| pubmed-article:143541 | pubmed:meshHeading | pubmed-meshheading:143541-M... | lld:pubmed |
| pubmed-article:143541 | pubmed:meshHeading | pubmed-meshheading:143541-R... | lld:pubmed |
| pubmed-article:143541 | pubmed:meshHeading | pubmed-meshheading:143541-S... | lld:pubmed |
| pubmed-article:143541 | pubmed:year | 1977 | lld:pubmed |
| pubmed-article:143541 | pubmed:articleTitle | Problems and solutions in achieving uniform dose distribution in superficial total body electron therapy. | lld:pubmed |
| pubmed-article:143541 | pubmed:publicationType | Journal Article | lld:pubmed |
